Inflammation Research

, Volume 44, Issue 10, pp 407–411 | Cite as

Pain due to nerve damage: Are inflammatory mediators involved

  • D. J. Tracey
  • J. S. Walker
Review

Abstract

Damage to peripheral nerves often results in pain and hyperalgesia. We suggest that nerve damage causes an inflammatory response in which cells associated with the nerve release inflammatory mediators such as eicosanoids; these mediators may contribute to the hyperalgesia which results from nerve injury. The cell types most likely to be responsible include macrophages and postganglionic sympathetic neurones. A better understanding of the mechanisms involved should lead to improved therapies for neuropathic pain.

Key words

Pain Hyperalgesia Neuropathy Nerve injury Inflammatory mediators 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Willner C, Low PA. Pharmacologic approaches to neuropathic pain. In: Dyck PJ, Thomas PK, editor. Peripheral Neuropathy. 3rd ed. Philadelphia: W.B. Saunders, 1993:vol 2.Google Scholar
  2. [2]
    Stanton-Hicks M, editor. Pain and the Sympathetic Nervous System. Boston: Kluwer, 1990.Google Scholar
  3. [3]
    Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988;33:87–107.PubMedGoogle Scholar
  4. [4]
    Tracey DJ, Romm MA, Yao NNL. Peripheral hyperalgesia in experimental neuropathy: exacerbation by neuropeptide Y. Brain Res 1995;669:245–54.PubMedGoogle Scholar
  5. [5]
    Tracey DJ, Cunningham JE, Romm MA. Peripheral hyperalgesia in experimental neuropathy: mediation byα2 adrenoreceptors on postganglionic sympathic terminals. Pain 1995;60:317–27.PubMedGoogle Scholar
  6. [6]
    Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990;43:205–18.PubMedGoogle Scholar
  7. [7]
    Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992;50:355–63.PubMedGoogle Scholar
  8. [8]
    Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983;306:686–8.PubMedGoogle Scholar
  9. [9]
    Laird JM, Bennett GJ. An electrophysiological study of dorsal horn neurons in the spinal cord of rats with an experimental peripheral neuropathy. J Neurophysiol 1993;69:2072–85.PubMedGoogle Scholar
  10. [10]
    Devor M. The pathophysiology of damaged peripheral nerves. In: Wall PD, Melzack R, editor. Textbook of Pain. 3rd ed. Edinburgh: Churchill Livingstone, 1994: 79–100.Google Scholar
  11. [11]
    Na HS, Leem JW, Chung JM. Abnormalities of mechanoreceptors in a rat model of neuropathic pain — possible involvement in mediating mechanical allodynia. J Neurophysiol 1993;70:522–8.PubMedGoogle Scholar
  12. [12]
    Koltzenburg M, Budweiser S, Kees S, Ochs G, Toyka KV. Receptive properties of nociceptors in a painful constriction neuropathy. Soc Neurosci Abstr 1993;19:325.Google Scholar
  13. [13]
    Sato J, Perl ER. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science 1991;251:1608–10.PubMedGoogle Scholar
  14. [14]
    McMahon SB. Mechanisms of sympathetic pain. Brit Med Bull 1991;47:584–600.PubMedGoogle Scholar
  15. [15]
    Matzner O, Devor M. Hyperexcitability at sites of nerve injury depends on voltage-sensitive Na+ channels. J Neurophysiol 1994;72:349–59.PubMedGoogle Scholar
  16. [16]
    Xie YK, Xiao WH, Li HQ. The relationship between new ion channels and ectopic discharges from a region of nerve injury. Science in China Ser B 1993;36:68–74.Google Scholar
  17. [17]
    Rang HP, Bevan S, Dray A. Nociceptive peripheral neurons: cellular properties: In: Wall PD, Melzack R, editors. Text-book of Pain. 3rd ed. Edinburgh: Churchill Livingstone, 1994:57–78.Google Scholar
  18. [18]
    Levine J, Taiwo Y. Inflammatory pain. In: Wall PD, Melzack R, editors. Textbook of Pain, 3rd ed. Edinburgh: Churchill Livingstone, 1994:45–56.Google Scholar
  19. [19]
    Schaible HG, Schmidt RF. Excitation and sensitization of fine articular afferents from cat's knee joint by prostaglandin E2. J Physiol 1988;403:91–104.PubMedGoogle Scholar
  20. [20]
    Taiwo YO, Levine JD. Effects of cyclooxygenase products of arachidonic acid metabolism on cutaneous nociceptive threshold in the rat. Brain Res 1990;537:372–4.PubMedGoogle Scholar
  21. [21]
    Davis KD, Treede RD, Raja SN, Meyer RA, Campbell JN. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 1991;47:309–17.PubMedGoogle Scholar
  22. [22]
    Levine JD, Taiwo YO, Collins SD, Tam JK. Noradrenaline hyperalgesia is mediated through interaction with sympathetic postganglionic neurone terminals rather than activation of primary afferent nociceptors. Nature 1986;323:158–60.PubMedGoogle Scholar
  23. [23]
    Birrell GJ, McQueen DS, Iggo A, Coleman RA, Grubb BD. PGI2-induced activation and sensitization of articular mechanonociceptors. Neurosci Lett 1991;124:5–8.PubMedGoogle Scholar
  24. [24]
    Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumour necrosis factorα in the development of inflammatory hyperalgesia. Br J Pharmacol 1992;107:660–4.PubMedGoogle Scholar
  25. [25]
    White DM, Basbaum AI, Goetzl EJ, Levine JD. The 15-lipoxygenase product, 8R, 15S-diHETE, stereospecifically sensitizes C-fiber mechanoheat nociceptors in hairy skin of rat. J Neurophysiol 1990;63:966–70.PubMedGoogle Scholar
  26. [26]
    Taiwo YO, Levine JD. Direct cutaneous hyperalgesia induced by adenosine. Neurosci 1990;38:757–62.Google Scholar
  27. [27]
    Taiwo YO, Levine JD, Burch RM, Woo JE, Mobley WC. Hyperalgesia induced in the rat by the amino-terminal octapeptide of nerve growth factor. Proc Natl Acad Sci USA 1991;88:5144–8.PubMedGoogle Scholar
  28. [28]
    Lewin GR, Rueff A, Mendell LM. Peripheral and central mechanisms of NGF-induced hyperalgesia. Europ J Neurosci 1994;6:1903–12.Google Scholar
  29. [29]
    Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci 1993;16:99–104.PubMedGoogle Scholar
  30. [30]
    Taiwo YO, Levine JD, Serotonin is a directly-acting hyperalgesic agent in the rat. Neurosci 1992;48:485–90.Google Scholar
  31. [31]
    Bisgaard H, Kristensen JK. Leukotriene B4 produces hyperalgesia in humans. Prostagland 1985;30:791–7.Google Scholar
  32. [32]
    Levine JD, Lau W, Kwiat G, Goetzl EJ. Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science 1984;225:743–5.PubMedGoogle Scholar
  33. [33]
    Steen KH, Reeh PW. Sustained graded pain and hyperalgesia from harmless experimental tissue acidosis in human skin. Neurosci Lett 1993;154:113–6.PubMedGoogle Scholar
  34. [34]
    Levine JD, Gooding J, Donatoni P, Borden L, Goetzl EJ. The role of the polymorphonuclear leukocyte in hyperalgesia. J Neurosci 1985;5:3025–9.PubMedGoogle Scholar
  35. [35]
    Clatworthy AL, Illich PA, Castro GA, Walters ET. Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behaviour in a rat model of neuropathic pain. Neurosci Lett 1995;184:5–8.PubMedGoogle Scholar
  36. [36]
    Zochodne DW. Epineurial peptides: a role in neuropathic pain? Can J Neurol Sci 1993;20:69–72.PubMedGoogle Scholar
  37. [37]
    Oldfors A. Macrophages in peripheral nerves. An ultrastructural and enzyme histochemical study on rats. Acta Neuropath 1980;49:43–9.PubMedGoogle Scholar
  38. [38]
    Frisén J, Risling M, Fried K. Distribution and axonal relations of macrophages in a neuroma. Neurosci 1993;55:1003–13.Google Scholar
  39. [39]
    Perry VH, Brown MC, Gordon S. The macrophage response to central and peripheral nerve injury. J Exp Med 1987;165:1218–23.PubMedGoogle Scholar
  40. [40]
    Perry VH. Macrophages and the Nervous System. Austin, Texas: R.G. Landes, 1994.Google Scholar
  41. [41]
    Nathan CF. Secretory products of macrophages. J Clin Invest 1987;79:319–26.PubMedGoogle Scholar
  42. [42]
    Nielsen BW, Mukaida N, Matsushima K, Kasahara T. Macrophages as producers of chemotactic proinflammatory cytokines. Immunol Series 1994;60:131–42.Google Scholar
  43. [43]
    Denis M. Human monocytes/macrophages: NO or no NO? J Leukocyte Biol 1994;55:682–4.PubMedGoogle Scholar
  44. [44]
    Kawabata A, Manabe S, Manabe Y, Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br J Pharmacol 1994;112:547–50.PubMedGoogle Scholar
  45. [45]
    Holthusen H, Arndt JO. Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci Lett 1994;165:71–4.PubMedGoogle Scholar
  46. [46]
    Levine JD, Coderre TJ, White DM, Finkbeiner WE, Basbaum AI. Denervation-induced inflammation in the rat. Neurosci Lett 1990;119:37–40.PubMedGoogle Scholar
  47. [47]
    Levine JD, Lam D, Taiwo Y, Donatoni P, Goetzl EJ. Hyperalgesic properties of 15-lipoxygenase products of arachidonic acid. Proc Natl Acad Sci USA 1986;83:5331–4.PubMedGoogle Scholar
  48. [48]
    Green PG, Luo J, Heller PH, Levine JD. Further substantiation of a significant role for the sympathetic nervous system in inflammation. Neurosci 1993;55:1037–43.Google Scholar
  49. [49]
    Coderre TJ, Basbaum AI, Levine JD. Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic efferents. J Neurophysiol 1989;62:48–58.PubMedGoogle Scholar
  50. [50]
    Khalil Z, Helme RD. Sympathetic neurons modulate plasma extravasation in the rat through a non-adrenergic mechanism. Clin Exp Neurol 1989;26:45–50.PubMedGoogle Scholar
  51. [51]
    Donnerer J, Amann R, Lembeck F. Neurogenic and non-neurogenic inflammation in the rat paw following chemical sympathectomy. Neurosci 1991;45:761–5.Google Scholar
  52. [52]
    Shir Y, Seltzer Z. Effects of sympathectomy in a model of causalgiform pain produced by partial sciatic nerve injury in rats. Pain 1991;45:309–20.PubMedGoogle Scholar
  53. [53]
    Kim SH, Na HS, Sheen K, Chung JM. Effects of sympathectomy on a rat model of peripheral neuropathy. Pain 1993;55:85–92.PubMedGoogle Scholar
  54. [54]
    Sherbourne CD, Gonzales R, Goldyne ME, Levine JD. Norepinephrine-induced increase in sympathetic neuron-derived prostaglandins is independent of neuronal release mechanisms. Neurosci Lett 1992;139:188–90.PubMedGoogle Scholar
  55. [55]
    Gonzales R, Sherbourne CD, Goldyne ME, Levine JD. Noradrenaline-induced prostalgandin production by sympathetic postganglionic neurons is mediated byα2-adrenergic receptors. J Neurochem 1991;57:1145–50.PubMedGoogle Scholar
  56. [56]
    Vanos DN, Ramamurthy S, Hoffman J. Intravenous regional block using ketorolac: preliminary results in the treatment of reflex sympathetic dystrophy. Anesth & Analg 1992;74:139–41.Google Scholar
  57. [57]
    Martin DL. Synthesis and release of neuroactive substances by glial cells. Glia 1992;5:81–94.PubMedGoogle Scholar
  58. [58]
    Murphy S, Pearce B, Jeremy J, Dandona P. Astrocytes as eicosanoid-producing cells. Glia 1988;1:241–245.PubMedGoogle Scholar
  59. [59]
    Hartung HP, Heininger K, Schafer B, Toyka KV. Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism. FASEB 1988;2:48–51.Google Scholar
  60. [60]
    Mantyh PW, Johnson DJ, Boehmer CG, et al. Substance P receptor binding sites are expressed by glia in vivo after neuronal injury. Proc Natl Acad Sci USA 1989;86:5193–7.PubMedGoogle Scholar
  61. [61]
    Meller ST, Dykstra C, Grzbycki D, Murphy S, Gebhart GF. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacol 1994;33:1471–8.Google Scholar
  62. [62]
    Reynolds ML, Woolf CJ. Reciprocal Schwann cell-axon interactions. Curr Opin Neurobiol 1993;3:683–93.PubMedGoogle Scholar
  63. [63]
    Constable AL, Armati PJ, Toyka KV, Hartung H-P. Production of prostanoids by Lewis rat Schwann cells in vitro. Brain Res 1994;635:75–80.PubMedGoogle Scholar
  64. [64]
    Bolin LM, Verity AN, Silver JE, Shooter EM, Abrams JS. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 1995;64:850–8.PubMedGoogle Scholar
  65. [65]
    Enerbäck L, Olsson Y, Sourander P. Mast cells in normal and sectioned peripheral nerve. Z Zellforsch 1965;66:596–608.PubMedGoogle Scholar
  66. [66]
    Zochodne DW, Nguyen C, Sharkey KA. Accumulation and degranulation of mast cells in experimental neuromas. Neurosci Lett 1994;182:3–6.PubMedGoogle Scholar
  67. [67]
    Ansselin AD, Pollard JD. Immunopathological factors in peripheral nerve allograft rejection: quantification of lymphocyte invasion and major histocompatibility complex expression. J Neurol Sci 1990;96:75–88.PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag, Basel 1995

Authors and Affiliations

  • D. J. Tracey
    • 1
  • J. S. Walker
    • 1
  1. 1.School of AnatomyUniversity of New South WalesSydneyAustralia

Personalised recommendations